@inproceedings{inproceedings, title = {{Infrequent zoledronic acid produces sustained increases in bone mineral density (BMD) in patients with cancer treatment induced bone loss (CTIBL)}}, url = {{}}, year = {{2006}}, month = {{1}}, author = {{Brown JE and Ellis SP and Lester JE and Gutcher S and Khanna T and Purohit O and Coleman RE}}, volume = {{32}}, journal = {{CANCER TREATMENT REVIEWS}}, pages = {{S19-S19}}, note = {{Accessed on 2025/04/17}}}